Concepedia

David Macarios

DM

Statistics

Publications

21

Citations

1.3K

H-Index

17

Active since

2006

Affiliations

Amgen (United States)(Current)

University of British Columbia

Policy Analysis (United States)

Duke Medical Center

Outcomes Research Consortium

David Macarios is an author at Amgen (United States) specializing in osteoporosis, medicine, and pharmacotherapy.

Publications per year

2006–2018

21

Publications

21

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

Nick Freemantle, Sacha Satram‐Hoang, En‐Tzu Tang et al. · Osteoporosis International · 2011 · 283 citations · Full text

Pharmacy, Pharmacotherapy, Pain Medicine +16

Compliance with drug therapy for postmenopausal osteoporosis

Derek Weycker, David Macarios, John Edelsberg et al. · Osteoporosis International · 2006 · 198 citations

Medicine, Pharmacology, Pharmacotherapy +12

Compliance with osteoporosis drug therapy and risk of fracture

Derek Weycker, David Macarios, John Edelsberg et al. · Osteoporosis International · 2006 · 124 citations

Medicine, Pharmacology, Pharmacotherapy +12

Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate

David L. Kendler, Michael R. McClung, Nick Freemantle et al. · Osteoporosis International · 2010 · 100 citations

Medicine, Pharmacotherapy, Clinical Pharmacology +11

The Association of Adherence to Osteoporosis Therapies with Fracture, All-Cause Medical Costs, and All-Cause Hospitalizations: A Retrospective Claims Analysis of Female Health Plan Enrollees with Osteoporosis

Rachel Halpern, Sheikh Usman Iqbal, Lewis E. Kazis et al. · Journal of Managed Care Pharmacy · 2011 · 94 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

1–5 of 21